GB1456349A - Composition and method for the treatment of mastitis - Google Patents
Composition and method for the treatment of mastitisInfo
- Publication number
- GB1456349A GB1456349A GB1331075A GB1331075A GB1456349A GB 1456349 A GB1456349 A GB 1456349A GB 1331075 A GB1331075 A GB 1331075A GB 1331075 A GB1331075 A GB 1331075A GB 1456349 A GB1456349 A GB 1456349A
- Authority
- GB
- United Kingdom
- Prior art keywords
- drying
- mastitis
- semi
- carbon atoms
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 208000004396 mastitis Diseases 0.000 title abstract 4
- 238000001035 drying Methods 0.000 abstract 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 abstract 2
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract 2
- 239000008158 vegetable oil Substances 0.000 abstract 2
- 229930186147 Cephalosporin Natural products 0.000 abstract 1
- 239000004099 Chlortetracycline Substances 0.000 abstract 1
- ASXBYYWOLISCLQ-UHFFFAOYSA-N Dihydrostreptomycin Natural products O1C(CO)C(O)C(O)C(NC)C1OC1C(CO)(O)C(C)OC1OC1C(N=C(N)N)C(O)C(N=C(N)N)C(O)C1O ASXBYYWOLISCLQ-UHFFFAOYSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 abstract 1
- 229930193140 Neomycin Natural products 0.000 abstract 1
- YJQPYGGHQPGBLI-UHFFFAOYSA-N Novobiocin Natural products O1C(C)(C)C(OC)C(OC(N)=O)C(O)C1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-UHFFFAOYSA-N 0.000 abstract 1
- 239000004100 Oxytetracycline Substances 0.000 abstract 1
- 229930182555 Penicillin Natural products 0.000 abstract 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 108010040201 Polymyxins Proteins 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 229940124587 cephalosporin Drugs 0.000 abstract 1
- 150000001780 cephalosporins Chemical class 0.000 abstract 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 abstract 1
- 229960004475 chlortetracycline Drugs 0.000 abstract 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 abstract 1
- 235000019365 chlortetracycline Nutrition 0.000 abstract 1
- 229960002227 clindamycin Drugs 0.000 abstract 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229960002222 dihydrostreptomycin Drugs 0.000 abstract 1
- ASXBYYWOLISCLQ-HZYVHMACSA-N dihydrostreptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O ASXBYYWOLISCLQ-HZYVHMACSA-N 0.000 abstract 1
- 229960003276 erythromycin Drugs 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- -1 fatty acid ester Chemical class 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 abstract 1
- 229960005287 lincomycin Drugs 0.000 abstract 1
- 239000002480 mineral oil Substances 0.000 abstract 1
- 235000010446 mineral oil Nutrition 0.000 abstract 1
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 abstract 1
- 229960004927 neomycin Drugs 0.000 abstract 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 abstract 1
- 229960001907 nitrofurazone Drugs 0.000 abstract 1
- 229960002950 novobiocin Drugs 0.000 abstract 1
- YJQPYGGHQPGBLI-KGSXXDOSSA-N novobiocin Chemical compound O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-KGSXXDOSSA-N 0.000 abstract 1
- 229960000625 oxytetracycline Drugs 0.000 abstract 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 abstract 1
- 235000019366 oxytetracycline Nutrition 0.000 abstract 1
- 229940049954 penicillin Drugs 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 229960005322 streptomycin Drugs 0.000 abstract 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 abstract 1
- 229960002180 tetracycline Drugs 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 229930101283 tetracycline Natural products 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1456349 Anti-mastitis composition UPJOHN CO 1 April 1975 [29 March 1974] 13310/75 Heading A5B An anti-mastitis composition comprises an anti-mastitis medicament dispersed in a gelled vehicle comprising a mineral oil or a non- drying, semi-drying, or drying vegetable oil, or a mixture thereof, other than a mixture consisting of a drying and a semi-drying vegetable oil, and from 0.5 to 5% by weight of a fatty acid ester derived from a saturated or unsaturated monocarboxylic acid having from 12 to 20 carbon atoms, and glycerin, propylene glycol, a mono- or dihydric alcohol of from 1 to 12 carbon atoms, or a polyethylene glycol having a M.W. of from 200 to 6000. The medicament may be, for example, a penicillin, neomycin, novobiocin, lincomycin, dihydrostreptomycin, streptomycin, erythromycin, polymyxin, tetracycline, oxytetracycline, chlortetracycline, clindamycin, nitrofurazone or a cephalosporin.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45603074A | 1974-03-29 | 1974-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1456349A true GB1456349A (en) | 1976-11-24 |
Family
ID=23811160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1331075A Expired GB1456349A (en) | 1974-03-29 | 1975-04-01 | Composition and method for the treatment of mastitis |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE827361A (en) |
| CA (1) | CA1052697A (en) |
| DE (1) | DE2512391C2 (en) |
| DK (1) | DK143438C (en) |
| FR (1) | FR2265408B1 (en) |
| GB (1) | GB1456349A (en) |
| NL (1) | NL7502808A (en) |
| ZA (1) | ZA751451B (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2273443A (en) * | 1992-12-08 | 1994-06-22 | Bimeda Res Dev Ltd | Veterinary composition for treating mastitis |
| WO2003097109A1 (en) * | 2002-05-22 | 2003-11-27 | Interag | Improvements in delivery technology |
| WO2005051352A1 (en) * | 2002-12-20 | 2005-06-09 | Pfizer Limited | Veterinary compositions for treating mastitis |
| US20100266708A1 (en) * | 2009-04-08 | 2010-10-21 | Rankin Scott A | Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
| US7828765B2 (en) | 2004-02-02 | 2010-11-09 | Bimeda Research & Development Ltd | Method and device for administering two components into the teat canal of a non-human animal |
| US7842791B2 (en) | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
| US8758831B2 (en) | 1996-12-18 | 2014-06-24 | Bimeda Research & Development Limited | Antiinfective free intramammary veterinary composition |
| US9180249B2 (en) | 2004-02-02 | 2015-11-10 | Bimeda Research & Development Limited | Method and device |
| US20160030398A1 (en) * | 2002-12-20 | 2016-02-04 | Zoetis Services Llc | Veterinary compositions for treating mastitis |
| US11491185B2 (en) | 2006-10-10 | 2022-11-08 | Wisconsin Alumni Research Foundation | Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1547164A (en) * | 1975-08-14 | 1979-06-06 | Beecham Group Ltd | Veterinary compositions |
| IT1190445B (en) * | 1985-11-08 | 1988-02-16 | Fatro Spa | VETERINARY COMPOSITIONS BASED ON ANTIMICROBIAL AGENTS AND THEIR USE |
| SE457693B (en) * | 1986-07-01 | 1989-01-23 | Drilletten Ab | COMPOSITION WITH REGULATED RELEASE WAS A BIOLOGICAL MATERIAL LOST OR DISPERSED IN AN L2 PHASE |
| DK16290D0 (en) * | 1990-01-19 | 1990-01-19 | Spindel & Spinnfluegelfab Veb | PATTERN TREATMENT NAME NECESSARY TO FIGHT MASTITIS |
| WO1998009520A1 (en) * | 1996-09-06 | 1998-03-12 | Minnesota Mining And Manufacturing Company | Antimicrobial compositions |
| FR2833500A1 (en) * | 2001-12-17 | 2003-06-20 | Veyron Et Froment Lab | New anhydrous, oily gel for use in the manufacture of e.g. cosmetics, oral dental products or pharmaceuticals |
-
1975
- 1975-03-06 CA CA221,421A patent/CA1052697A/en not_active Expired
- 1975-03-10 ZA ZA00751451A patent/ZA751451B/en unknown
- 1975-03-10 NL NL7502808A patent/NL7502808A/en not_active Application Discontinuation
- 1975-03-14 DK DK106175A patent/DK143438C/en not_active IP Right Cessation
- 1975-03-21 DE DE2512391A patent/DE2512391C2/en not_active Expired
- 1975-03-28 BE BE154927A patent/BE827361A/en not_active IP Right Cessation
- 1975-03-28 FR FR7509948A patent/FR2265408B1/fr not_active Expired
- 1975-04-01 GB GB1331075A patent/GB1456349A/en not_active Expired
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2273443A (en) * | 1992-12-08 | 1994-06-22 | Bimeda Res Dev Ltd | Veterinary composition for treating mastitis |
| GB2273441A (en) * | 1992-12-08 | 1994-06-22 | Bimeda Res Dev Ltd | Veterinary composition for treating mastitis |
| GB2273655A (en) * | 1992-12-08 | 1994-06-29 | Bimeda Res Dev Ltd | Veterinary compositions for treating mastitis |
| GB2273441B (en) * | 1992-12-08 | 1997-01-08 | Bimeda Res Dev Ltd | Veterinary compositions for treating mastitis |
| GB2273443B (en) * | 1992-12-08 | 1997-01-08 | Bimeda Res Dev Ltd | Veterinary composition for the treatment of mastitis |
| GB2273655B (en) * | 1992-12-08 | 1997-01-08 | Bimeda Res Dev Ltd | Veterinary compositions for the treatment of mastitis |
| US8758831B2 (en) | 1996-12-18 | 2014-06-24 | Bimeda Research & Development Limited | Antiinfective free intramammary veterinary composition |
| WO2003097109A1 (en) * | 2002-05-22 | 2003-11-27 | Interag | Improvements in delivery technology |
| US7842791B2 (en) | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
| AU2003283757C1 (en) * | 2002-12-20 | 2014-05-01 | Zoetis Services Llc | Veterinary compositions for treating mastitis |
| JP2006515865A (en) * | 2002-12-20 | 2006-06-08 | ファイザー・リミテッド | Veterinary composition for the treatment of mastitis |
| AU2003283757B2 (en) * | 2002-12-20 | 2010-01-21 | Zoetis Services Llc | Veterinary compositions for treating mastitis |
| US20160030398A1 (en) * | 2002-12-20 | 2016-02-04 | Zoetis Services Llc | Veterinary compositions for treating mastitis |
| WO2005051352A1 (en) * | 2002-12-20 | 2005-06-09 | Pfizer Limited | Veterinary compositions for treating mastitis |
| US9180249B2 (en) | 2004-02-02 | 2015-11-10 | Bimeda Research & Development Limited | Method and device |
| US8353877B2 (en) | 2004-02-02 | 2013-01-15 | Bimeda Research & Development Limited | Method for administering two components into the teat canal of a non-human animal |
| US7828765B2 (en) | 2004-02-02 | 2010-11-09 | Bimeda Research & Development Ltd | Method and device for administering two components into the teat canal of a non-human animal |
| US11491185B2 (en) | 2006-10-10 | 2022-11-08 | Wisconsin Alumni Research Foundation | Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
| US20100266708A1 (en) * | 2009-04-08 | 2010-10-21 | Rankin Scott A | Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
| US9956167B2 (en) * | 2009-04-08 | 2018-05-01 | Wisconsin Alumni Research Foundation | Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
| US10744085B2 (en) | 2009-04-08 | 2020-08-18 | Wisconsin Alumni Research Foundation | Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2265408B1 (en) | 1978-08-04 |
| NL7502808A (en) | 1975-10-01 |
| DK143438C (en) | 1981-12-21 |
| DK106175A (en) | 1975-09-30 |
| FR2265408A1 (en) | 1975-10-24 |
| DE2512391C2 (en) | 1986-10-09 |
| DE2512391A1 (en) | 1975-10-02 |
| BE827361A (en) | 1975-09-29 |
| CA1052697A (en) | 1979-04-17 |
| ZA751451B (en) | 1976-02-25 |
| AU7909675A (en) | 1976-09-16 |
| DK143438B (en) | 1981-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1456349A (en) | Composition and method for the treatment of mastitis | |
| BE766473A (en) | PROCESS FOR THE PREPARATION OF HYDROXY ACID FATTY ESTERS | |
| CA1029390A (en) | Process for preparing an unsaturated ester | |
| AU8778175A (en) | Partial esters of hydroxy polycarboxylic acids | |
| CA933938A (en) | Process for producing esters of epoxy fatty acids | |
| AU505456B2 (en) | Method for producing an unsaturated ester | |
| CA1033757A (en) | Process for preparing the pentaerythritol ester of phosphorohalidous acid | |
| SE7408960L (en) | ||
| GB1544819A (en) | Antibiotic substances derived from antibiotic 67-694(rosamicin)and processes for their preparation | |
| GB1299145A (en) | Esters of 1,3 diols and 1,3,5 x-polyols as additives for baked goods | |
| CA953736A (en) | Process for preparing hydroxy citronella by saponification of the hydroxy ester | |
| ES386180A1 (en) | Modifying keratinous textiles and fibres with mercaptan polyesters | |
| CA921042A (en) | Process for preparing phosphoric acid esters of fatty acid mono- or di-glycerides | |
| ES399966A1 (en) | Nut and gear assemblies for use in engine starter motors | |
| ES424022A1 (en) | Fatty acid ester mixtures liquid at low temperatures and process | |
| CA944760A (en) | Method for polymerizing fatty acids | |
| CA1001617A (en) | Unsaturated ester sulfur compositions used as lubricant additives and lubricant compositions containing them | |
| ES395615A1 (en) | A procedure for the preparation of a substantially anhydraic composition intended for a pharmaceutical vehicle. (Machine-translation by Google Translate, not legally binding) | |
| CA849564A (en) | Process for the manufacture of unsaturated esters of carboxylic acids | |
| ES410021A1 (en) | Amidothionophosphoric acid esters | |
| JPS4942831B2 (en) | ||
| AU485555B2 (en) | Improved process for preparing the pentaerythritol ester of phosphorohalidous acid | |
| AU2972371A (en) | Process for polymerizing unsaturated fatty acids and their esters | |
| GB693611A (en) | Manufacture of alkylene imine esters | |
| NL167192B (en) | Process for the preparation of conjugated unsaturated fatty acids or their esters. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 414F | Notice of opposition given (sect. 14/1949) | ||
| 414B | Case decided by the comptroller ** grants allowed (sect. 14/1949) | ||
| PS | Patent sealed | ||
| 704A | Declaration that licence is not available as of right for an excepted use (par. 4a/1977) | ||
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19940401 |